Inovio Pharmaceuticals, Inc. (INO) Gets Bulls' Attention

Inovio Pharmaceuticals Inc (INO) traders are banking on additional upside

Digital Content Group
Apr 14, 2015 at 1:28 PM
facebook twitter linkedin


Inovio Pharmaceuticals Inc (NASDAQ:INO) is having a standout day -- jumping 4.2% to trade at $10.29, and bringing its year-to-date lead to 12%. Option traders have responded, setting their sights on the drugmaker's calls.

Getting into the data, INO calls are being exchanged at twice the usual intraday rate. By the numbers, there are 767 contracts on the tape, more than three times the 208 puts traded. Looking more closely, one group of speculators may be banking on the shares to extend their lead deeper into double-digit territory, buying to open the stock's May 10 call for a volume-weighted average price (VWAP) of $1.20. As such, breakeven on the transaction is $11.20 (strike plus VWAP) -- territory not explored since mid-November.

Bullish betting is business as usual for INO. During the last 10 days at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), more than 1,100 calls have been bought to open, versus fewer than 20 puts. Echoing this, the stock's Schaeffer's put/call open interest ratio (SOIR) -- measuring open interest among options expiring in three months or less -- sits at 0.29, in the call-skewed 5th percentile of its annual range.

Option players aren't the only ones enamored with Inovio Pharmaceuticals Inc (NASDAQ:INO). All six analysts tracking the shares have designated them a "strong buy," and the equity's average 12-month price target of $20.80 is more than double current trading levels. However, as mentioned last week, short sellers remain skeptical of INO.

 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

SCHAEFFER'S JULY STOCKS REPORT AD
 


 


 
Special Offers from Schaeffer's Trading Partners